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Abstract 
Background: Feline leishmaniosis caused by Leishmania infantum is considered a rare disease in endemic areas, 
whereas subclinical infections are common. Immune response plays a key role in driving the course of L. infantum 
infection in other host species; however, the feline cell‑mediated immune response to L. infantum infection has not 
yet been investigated. The aim of this study was to determine the cell‑mediated immune response specific to L. infan-
tum by means of interferon (IFN)‑γ release in whole blood assay from cats living in endemic areas (66 in Sicily and 113 
in Catalonia) and to compare with antibody levels to L. infantum [enzyme‑linked immunosorbent assay (ELISA) and 
immunofluorescence antibody test (IFAT)], blood parasite load and retroviral infections.
Results: Most cats (n = 140) were L. infantum antibody negative and only 22% (n = 39) were positive. Only 9 and 2% 
of tested cats had a feline immunodeficency virus (FIV) infection or a feline leukemia virus (FeLV) infection, respec‑
tively. Thirty‑two cats out of 179 (18%) produced IFN‑γ after stimulation with L. infantum soluble antigen (LSA) while 
the majority of cats (93%) produced IFN‑γ after stimulation with concanavalin A (ConA). Six LSA‑IFN‑γ‑producer cats 
were seropositive (three to ELISA and five to IFAT) but they were polymerase chain reaction (PCR) negative, while only 
one cat was antibody‑ and PCR‑positive. Significant positive correlations were found between IFN‑γ concentrations 
after stimulation with LSA and ConA, and between serology and PCR testing. No association was found between FIV 
status and LSA or ConA‑IFN‑γ production. Combining PCR, serology and specific IFN‑γ concentration results, we found 
that 36% of cats studied were exposed to L. infantum.
Conclusions: As expected, cats from endemic areas produce IFN‑γ after ex vivo blood stimulation with LSA and 
therefore are able to activate a cell‑mediated adaptive immune response against the parasite that is variably associ‑
ated with antibody or blood PCR positivity. The association of this assay to serological and molecular tests provides a 
better estimate of cat exposure to L. infantum.
Keywords: Adaptive immunity, Feline, Humoral immunity, IFN‑γ release whole blood assay, Leishmania infantum, 
PCR, Retroviral infections
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Background
Leishmaniosis is a vector-borne disease of humans and 
animals caused in Europe by Leishmania infantum and 
transmitted by female sand flies of the genus Phlebotomus 
[1–3]. Dogs are considered the main reservoir of L. infan-
tum but there is clear evidence that some wild and synan-
thropic mammals and domestic cats are able to infect 
sand flies and they play a variable role in a reservoir sys-
tem according to local and ecological peculiarities [3–5].
Feline leishmaniosis (FeL) due to L. infantum infec-
tion was described, for the first time, in 1912 by Sergent 
et al. [6] and since then it has been globally reported in 
endemic areas [5, 7]. While subclinical feline infections 
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are common in areas where canine leishmaniosis (CanL) 
is endemic, clinical illness due to FeL is rare [7, 8]. Clini-
cal disease is frequently associated with possible impaired 
immunocompetence, as in case of retroviral co-infec-
tions, immunosuppressive therapy, or malignant neopla-
sia [7, 8]. The immune response plays a crucial role in the 
control of Leishmania infection. Albeit some differences 
according to the host species, T cells modulate and ori-
ent, through cytokine production, macrophage reaction 
to the parasite [9–11]. Antigen processing cells (dendritic 
cells and macrophages) present L. infantum antigens to 
 CD4+ T cells that modulate the type of immune response 
[12]. A T helper 1 (Th1) oriented immune response, asso-
ciated with production of interferon-gamma (IFN-γ), 
interleukin (IL)-2 and tumor necrosis factor alpha (TNF-
α), stimulates phagocytosis by macrophages, their pro-
duction of nitric oxide and reactive oxygen intermediate 
and consequent phagocyte-based parasite intracellular 
elimination [11, 13]. Conversely, in dogs susceptibility 
to infection and disease progression is mediated pre-
dominantly by a non-protective T helper 2 (Th2) immune 
response and the production of cytokines such as IL-4, 
IL-10, IL-13 and transforming growth factor beta (TGF-
β) which are associated with downregulation of the cel-
lular immune response, a high level of antibodies, and L. 
infantum dissemination [9–11].
Different feline innate and adaptive immune responses 
might account for the observed lower prevalence of L. 
infantum infection as well as clinical leishmaniosis in 
cats as compared to dogs [7, 14]. It is well recognized that 
cats appear to be less frequently affected by arthropod-
borne diseases when compared to dogs, although no 
important differences are known between the canine and 
feline immune systems [15]. Interestingly, to the best of 
our knowledge, no studies have so far evaluated L. infan-
tum-specific cell-mediated immunity in cats. However, 
detection of IFN-γ in antigen stimulated whole blood or 
peripheral blood mononuclear cells (PBMCs) was used in 
cats to evaluate cellular immune response mechanisms to 
other pathogens (e.g. feline coronavirus or Toxoplasma 
gondii) [16–18].
The main aim of this study was to determine the L. 
infantum-specific cellular immune response in cats by 
means of the evaluation of IFN-γ production in stimu-
lated blood from cats living in endemic areas of CanL 
(Catalonia and Sicily) and correlate it with L. infantum 
antibody levels, blood parasitemia, and retroviral status.
Methods
Study areas, cats and sampling
Cats were sampled from March 2016 to April 2017 in 
two Mediterranean endemic areas of CanL: Sicily (Italy) 
and Catalonia (Spain). Catalan samples were collected 
at the Fundació Hospital Clínic Veterinari (Bellaterra, 
Barcelona), Hospital Clinic Xinesca (Vilassar de Mar, 
Barcelona) and Vetamic Hospital Veterinari Cambrils 
(Cambrils, Tarragona). Sicilian samples were collected at 
Ospedale Veterinario Didattico (Università degli Studi di 
Messina, Dipartimento di Scienze Veterinarie, Messina) 
and at Ambulatorio Veterinario Santa Lucia (Lipari, 
Messina). Inclusion criteria for enrollment included the 
exposure to at least one sand-fly season and no treatment 
with repellent ectoparasiticides (i.e. pyrethroid prod-
ucts). Sex, age class, breed, clinical status, lifestyle of pet 
cats (indoors, outdoors), and number of stray cats at each 
sampling site are summarized in Table 1. Age was classi-
fied as follows: young (6–18 months); adult (between 19 
and 96 months); and old (> 96 months). The clinical sta-
tus of cats was defined as “sick” or “apparently healthy” 
based on data available from history and physical exami-
nation. Sick cats were considered when clinical signs 
compatible with FeL (i.e. lymph node enlargement, skin, 
mucosal or eye lesions, stomatitis, weight loss, chronic 
kidney disease, anaemia) were found as previously 
described [7]. Apparently healthy cats were considered 
when no clinical signs were present with the exception 
of four cats admitted because of trauma that were also 
included in this group.
One milliliter of blood, aseptically put into a heparin 
tube, was used for whole blood assay within 24  h after 
blood sampling. EDTA blood and blood serum were also 
obtained and immediately aliquoted and stored at -20 °C 
until processed for DNA extraction and serological inves-
tigations, respectively.
Feline IFN‑γ release whole blood assay
Whole blood assays were performed as previously 
described in dogs [10] with some minor modifications to 
adapt the technique to the smaller volume of blood avail-
able. Heparinized blood was diluted at a ratio of 1:10 with 
medium and after five days the supernatant was collected 
from unstimulated cultured cells. Two aliquots of diluted 
blood were respectively cultured with Concanavalin-
A (ConA) or L. infantum soluble antigen (LSA) to sub-
sequently recover supernatants from stimulated blood 
cells.
Feline IFN-γ concentrations were determined using a 
specific DuoSet® ELISA (Development Sistems R&D™, 
Abingdon, UK) according to the manufacturer’s instruc-
tions with some modifications. The standard curve for 
IFN-γ started with 4000 pg/ml and serial 2-fold dilu-
tions were made until a concentration of 31.25 pg/ml was 
reached. Duplicates of supernatants obtained from whole 
blood culture were tested in the ELISA plates. The opti-
cal density was measured with an ELISA reader (Anthos 
2020, Cambridge, UK) at wavelength of 450 nm. The 
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standard curve was calculated using a computer generat-
ing four parameters logistic curve-fit with the program 
MyAssays (http://www.myass ays.com/). Cats were classi-
fied as IFN-γ producers (IFNγ-p) when the L. infantum-
specific IFN-γ concentration, after subtracting the value 
obtained with supernatant of unstimulated cell cultures, 
was higher than the last detectable dilution of the stand-
ard curve (31.25 pg/ml). Similarly, cats were classified as 
IFN-γ non-producers (IFNγ-np) when the L. infantum-
specific IFN-γ concentration, after subtracting the value 
obtained with supernatant of unstimulated cell cultures, 
was less than 31.25 pg/ml or at undetectable levels. The 
same cat classification was made for IFN-γ production 
obtained by ConA stimulation of whole blood cultures.
Leishmania infantum antibody detection
IFAT
Anti-L. infantum IgG antibodies were detected using the 
L. infantum (strain MHOM/IT/80/IPT1) antigen pro-
duced by C.Re.Na.L. (Centro di Referenza Nazionale per 
la Leishmaniosi, Palermo, Italy). Fluoresceinated anti-cat 
immunoglobulin G (IgG) antibody (working anti-feline 
IgG (H+L)-FITC, Fuller Laboratories, Fullertone, CA, 
USA) was used. The manufacturer’s protocol was fol-
lowed, and the end point titer of positive samples was 
determined preparing serial 2-fold dilutions of serum 
starting from 1:20. The cut-off value for positivity was set 
at 1:80 [19, 20]. Fluorescence microscope readings were 
made by a unique operator (MM).
In‑house ELISA
ELISA was performed as previously described [20, 21]. 
All plates included the serum from a sick cat from Cyprus 
with a confirmed infection with L. infantum as positive 
control, and the serum of a cat from an area where leish-
maniosis was not endemic as a negative control. All sam-
ples were run in duplicate. The cut-off was established at 
12.3 ELISA units (EU) (mean ± 3 standard deviations of 
sera from 81 cats from the UK, a non-endemic area).
Detection of anti‑FIV antibodies and FeLV p27 antigen
Due to insufficient amounts of serum, only 149 cats out 
of 179 were tested for feline immunodeficiency virus 
(FIV) and 171 for feline leukemia virus (FeLV) infections. 
A total of 133 feline sera were tested for the detection 
of FeLV p27 antigen and anti-FIV antibodies by a rapid 
ELISA (SNAP Combo Plus FeLV antigen and FIV anti-
body test, Idexx Laboratories, Westbrook, ME, USA), 
according to the manufacturer’s protocol. Because of 
serum paucity, other cats were tested by a commer-
cial ELISA: 38 serum samples were tested for FeLV p27 
antigen by INgezim-FeLV DAS (Ingenasa, Madrid, Spain) 
and only 16 feline sera for anti-FIV antibodies by INge-
zim-FIV (Ingenasa).
Blood DNA extraction and Leishmania real‑time PCR
Total DNA was extracted from EDTA blood using the 
DNA Gene extraction kit (Sigma Aldrich, Saint Louis, 
MO, USA) following the manufacturer’s instructions 
with some modifications. Forty microliters of protein-
ase K solution were added to all samples. Four hundred 
microliters of whole blood were used for all the samples. 
Blood from a clinically healthy non-infected cat was 
used as a control for DNA contamination in every DNA 
extraction performed. The real-time polymerase chain 
reaction (RT-PCR) was carried out in a CFX96 Real-time 
System (Bio-Rad Laboratories s.r.l., Hercules, CA, USA) 
using TaqMan Master Mix (Applied Biosystems by Ther-
moFisher, Waltham, MA, USA) and performed as previ-
ously described [22].
Statistical analysis
A minimum sample size of 173 cats was calculated for cat 
enrollment, based on the prevalence of feline L. infantum 
infection in areas under study (Catalonia and Sicily) [14, 
19, 20, 23], and on the assumptions of 99% confidence 
level and 5% precision [24].
Fisher’s exact test was used to compare groups defined 
by categorical variables. Results of tests for L. infantum 
exposure of cats did not pass the D’Agostino-Pearson 
normality test. Accordingly, the Mann-Whitney U-test 
was used to compare unmatched continuous data and 
the Wilcoxon signed-rank test to compare paired con-
tinuous variables. Spearman’s correlation coefficient was 
calculated to evaluate relationships between ELISA, IFAT 
and PCR results and between levels of IFN-γ, anti-Leish-
mania antibodies, and L. infantum DNA in blood of cats 
studied. P-values<0.05 were considered significant. The 
D’Agostino-Pearson normality test and Fisher’s exact test 
were performed using Prism 7 for Mac IOS and all other 
tests were performed using SPSS software v.17.0 for Win-
dows. Finally, Cohen’s kappa coefficient was measured 
analyzing results of ELISA and IFAT with blood PCR 
(https ://idost atist ics.com/cohen -kappa -free-calcu lator ).
Results
Cats
Sex, breed, age class, lifestyle, origin (region and munici-
pality) and clinical status of 179 cats included in the study 
are summarized in Table 1. The median of age of cats was 
24 months [25–75 percentile (25–75) = 18–48 months; 
interquartile range (IQR) =  30 months]. There were no 
differences between the two regions related to the vari-
ables sex, breed, age class and lifestyle of cats. Conversely, 
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cats from Sicily were more frequently found sick com-
pared to Catalan cats (Fisher’s exact test, P < 0.0001).
Leishmania infantum serological tests
Results of serological tests are shown in Table  2 and 
Fig.  1. A slight positive correlation (Spearman’s cor-
relation coefficient, rs =  0.342, P  =  0.0001) was found 
between ELISA and IFAT. However, only 11 of the 39 cats 
positive to IFAT and/or ELISA were positive to both tests 
(28%) and an agreement of 78.1% was found when these 
tests were compared (Cohen’s kappa coefficient =  0.18, 
i.e. slight agreement beyond chance). No differences were 
found regarding seropositivity and variables studied. 
IFAT
IFAT results based on cat provenience and clinical status 
are summarized in Table 2. The median IFAT titer was 80 
[(25–75) = 80–320]. No differences of IFAT titers were 
found between Sicilian and Catalonian cats. However, 
Catalonian cats from Bellaterra were more frequently 
found positive to IFAT than those from Vilassar de Mar 
(Fisher’s exact test, P = 0.0453).
ELISA
ELISA results based on cat provenience and clinical 
status are summarized in Table  2. The median value of 
positive samples was 19 EU [(25–75) = 13.5–107.3 EU]. 
Old cats (4/14, 29%) were more frequently positive than 
young cats (1/35, 3%) (Fisherʼs exact test, P = 0.0194). 
Sicilian cats were statistically more frequently found 
positive to ELISA than Catalan cats (Fisher’s exact test, 
P = 0.0282) and the ELISA median value for Sicilian cats 
was significantly higher [6.1 EU; (25–75) = 1.2–9.5 EU] 
than the result observed in Catalan cats [median: 3.7 EU; 
(25–75) = 1.9–6.4 EU] (Mann-Whitney U-test, Z = -249, 
P < 0.0001).
Leishmania real‑time PCR
PCR results based on cat provenience and clinical status 
are summarized in Table 2. Only 9 cats (5%) were Leish-
mania-PCR positive (Fig. 1) and the median parasite load 
was 60 L. infantum amastigotes/ml [(25–75) = 10–128.5]. 
Leishmania-PCR positive cats were more frequently pos-
itive by serology (89% by IFAT and 78% by ELISA) than 
Leishmania-PCR negative cats (13% by IFAT and 7% by 
ELISA) (Fisher’s exact test, P<0.0001). In addition, anti-
body level measured by IFAT (Mann-Whitney U-test, 
Z = 86.5, P < 0.0001) and ELISA (Mann-Whitney-U test, 
Z = 219, P  <  0.0001) of Leishmania-PCR positive cats 
was significantly higher when compared to Leishmania-
PCR negative cats. Moreover, a positive correlation was 
found between PCR and ELISA (Spearman’s correlation 
coefficient, rs = 0.272, P = 0.0001) with an agreement of 
86.1% (Cohen’s kappa coefficient = 0.25, i.e. fair agree-
ment) as well as a positive correlation between PCR 
and IFAT (Spearman’s correlation coefficient, rs = 0.347, 
P = 0.0001) with an agreement of 80.1% (Cohen’s kappa 
coefficient = 0.18, i.e. slight agreement). No other differ-
ences were found in positive PCR prevalence according 
to variables under study.
Anti‑FIV antibodies and FeLV p27 antigen
Thirteen cats (9%) were antibody-positive to FIV and 
4 (2%) were antigen-positive to FeLV (Table  2). FIV 
and FeLV co-infections were never detected. All FeLV-
positive cats were from Catalonia while there was no 
Table 2 Number and percentage of cats positive to L. infantum and retroviruses according to their geographical distribution and 
clinical status
Abbreviations: FIV, feline immunodeficiency virus; FeLV, feline leukemia virus; LSA, Leishmania soluble antigen; ConA, concanavalin A
Provenience or clinical status
(N; %)
Serology Blood PCR IFN‑γ assay Retroviruses
Total ELISA IFAT LSA ConA FIV FeLV
Sicily
 Messina City (N = 24; 36) 5 (21) 4 (17) 3 (12) 1 (4) 6 (25) 24 (100) 2 (8) 0 (0)
 Aeolian Islands (N = 42; 64) 9 (21) 7 (17) 6 (14) 2 (5) 5 (12) 39 (93) 4 (9) 0 (0)
 Total (N = 66; 37) 14 (21) 11 (17) 9 (14) 3 (4) 11 (17) 63 (95) 6 (9) 0 (0)
Catalonia
 Vilassar de Mar (N = 22;19) 1 (4) 0 (0) 1 (4) 1 (4) 2 (9) 22 (100) 1 (5) 0 (0)
 Cambrils (N = 45; 40) 8 (18) 2 (4) 6 (13) 1 (2) 5 (11) 40 (89) 4 (12) 1 (2)
 Bellaterra (N = 46; 41) 16 (35) 6 (13) 15 (33) 4 (9) 14 (30) 41 (89) 2 (6) 3 (7)
Total (N = 113; 63) 25 (22) 8 (7) 22 (19) 6 (5) 21 (19) 103 (91) 7 (8) 4 (4)
 Apparently healthy (N = 119; 66) 21 (18) 6 (5) 19 (16) 3 (2) 21 (18) 108 (91) 8 (7) 2 (2)
 Sick (N = 60, 34) 18 (30) 13 (22) 12 (20) 6 (10) 11 (18) 58 (97) 5 (8) 2 (3)
 All cats (N = 179; 100) 39 (22) 19 (11) 31 (17) 9 (5) 32 (18) 166 (93) 13 (9) 4 (2)
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difference in FIV prevalence between cats enrolled in 
Sicily (9%) and in Catalonia (8%) (Table  2). Moreover, 
there were no statistical differences in prevalence of anti-
L. infantum antibodies or Leishmania DNA positivity in 
cats positive to FIV or FeLV compared to the negatives. 
Similarly, no statistical difference was found for the lev-
els of anti-L. infantum antibodies or L. infantum parasite 
load between FIV- or FeLV-positive cats and the negative 
ones. Interestingly, four FIV- and two FeLV-positive cats 
were also positive to one or more L. infantum diagnostic 
tests. Only one FeLV- and two FIV-positive cats produced 
IFN-γ after LSA stimulation. Moreover, two of them were 
positive to both serological tests and blood PCR. Con-
versely, 107 cats were L. infantum and retrovirus nega-
tive and 21 produced IFN-γ after LSA stimulation. There 
were no statistical differences in IFN-γ productions (after 
LSA or ConA stimulations) between FIV- or FeLV-posi-
tive and negative cats.
IFN‑γ production
The frequency of cats producing IFN-γ after stimulation 
with LSA or ConA is summarized in Table  2 according 
to their provenience and clinical status. A higher num-
ber of cats produced IFN-γ after stimulation with ConA 
(166/179, 93%) than with LSA (32/179, 18%) (Fisher’s 
exact test, P < 0.0001) (Table 2). Levels of IFN-γ accord-
ing to serological and PCR results, and clinical status are 
summarized in Table  3. The median of the IFN-γ con-
centration of LSA-IFN-γ producer cats (IFNγ-p) was 
significantly lower than concentration obtained with 
ConA stimulation [1115 pg/ml (25–75) = 199.9–2931 pg/
ml] (Wilcoxon signed-rank test, Z = -11.108, P < 0.0001). 
The unique IFNγ-p cat positive to Leishmania-PCR (125 
L. infantum amastigotes/ml) tested high positive by both 
IFAT (titer 40960) and ELISA (> 346.3 EU). This cat was 
adult, FeLV-positive, suffered from squamous cell carci-
noma and Leishmania amastigotes were detected at cyto-
logical evaluation of the neoplastic cutaneous lesion.
Sick and apparently healthy cats had the same preva-
lences of IFNγ-p individuals (Table  2); however, sick 
IFNγ-p cats had a significantly higher level of LSA IFN-γ 
(Mann-Whitney U-test, Z = 47, P = 0.0056) (Table  3). 
The prevalence of cats producing IFN-γ after stimula-
tion with ConA was above 90% in both groups (Table 2); 
however, among 64 cats exposed to L. infantum (i.e. posi-
tive to at least one specific test), sick individuals (n = 25) 
had a significantly higher median concentration [2159 
pg/ml; (25–75) = 965.3–4508 pg/ml] than apparently 
healthy cats (n = 39) [1712.5 pg/ml; (25–75) = 87.1–2946 
pg/ml] (Mann-Whitney U-test, Z = 339, P = 0.0117). 
The concentration of IFN-γ produced after stimulation 
with ConA was significantly higher in the IFNγ-p group 
(Mann-Whitney U-test, Z = 1473, P = 0.0008) (Table  3) 
and IFN-γ concentrations after ConA or LSA stimula-
tions were positively correlated (Spearman’s correlation 
coefficient, rs = 0.264, P = 0.0001). Additionally, ELISA 
antibody levels were positively correlated with IFN-γ 
Fig. 1 Percentage of cats positive to L. infantum according respectively to: all specific tests performed, serology (IFAT and/or ELISA) and blood PCR, 
serology (IFAT and/or ELISA), IFAT, ELISA, blood PCR, and LSA IFN‑γ assay
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concentrations from ConA stimulated cultures (Spear-
man’s correlation coefficient, rs = 0.209, P = 0.0001).
Overall L. infantum frequency of infection
An overall L. infantum prevalence of 36% calculated by 
PCR, serology and LSA IFN-γ assay was obtained in the 
population studied (Fig. 1) and no differences were found 
between Catalonia (35%) and Sicily (36%), the sites of 
each region studied, or between apparently healthy (33%) 
and sick cats (42%).
Discussion
To our knowledge, this study demonstrated for the first 
time that cats naturally exposed to L. infantum infection 
produced IFN-γ after ex vivo whole blood stimulation 
with L. infantum antigens, as occurs in dogs, humans and 
laboratory animals [10, 25, 26].
Parasite-specific IFN-γ production was found in 18% 
of enrolled cats and it was associated with antibody pro-
duction in only seven of the 32 IFNγ-p cats of this study. 
Both types of adaptive immune responses were therefore 
variably combined in single cats and a wide immunologi-
cal spectrum may exist also in cats as already reported in 
dogs and humans [10, 27].
The present study did not aim to evaluate the para-
site T cell mediated immunity of clinical cases of FeL 
but based on data available from physical examination, 
the frequency of IFNγ-p individuals was not different in 
apparently healthy and sick cats. Similarly, there was no 
difference in the prevalence of sick cats between IFNγ-p 
and IFNγ-np cats positive to serological or blood PCR 
tests. However, sick IFNγ-p cats produced a significantly 
higher level of IFN-γ. Moreover, the unique cat with clin-
ical FeL confirmed by cytology was IFNγ-p and, despite 
possible immunosuppression due to FeLV infection and 
to neoplasia, this cat reached an IFN-γ level around the 
median value. In the present study, retroviral infection 
per se did not affect adaptive immune response of cats to 
L. infantum, but a limitation was the very low number of 
FIV (n = 13) or FeLV (n = 4) infected enrolled cats.
Dogs with mild or moderate CanL produce IFN-γ and 
the lack of production is restricted to severe disease [10, 
28]. Prospective clinical studies with cats with confirmed 
clinical leishmaniosis are needed to further evaluate if 
IFN-γ is as possible marker for staging the severity of dis-
ease and evaluating efficacy of therapy as documented in 
dogs [10, 28].
IFN-γ production after stimulation with ConA was 
obtained in almost all cats and it was not associated with 
any variable, including clinical status, retroviral infec-
tions or exposure to L. infantum. These findings are sim-
ilar to data from studies of CanL [10, 28]. As expected, 
concentrations of ConA-IFN-γ were significantly higher 
than LSA-IFN-γ and they were positively correlated. Pro-
duction of ConA-IFN-γ suggests non-specific T cell acti-
vation. Surprisingly, when considering cats exposed to 
L. infantum (i.e. positive to at least one the specific tests 
performed), sick individuals produced a significantly 
higher level of ConA compared to apparently healthy 
individuals. This finding is unusual, and it is difficult to 
Table 3 Concentrations of IFN-γ and level of positivity to L. infantum tests according to results of tests and the clinical status in IFN‑γ 
producer and non‑producer cats
a Median values (25th and 75th percentiles)











 Serology‑ and PCR‑negative 25 (14) 174 (64.2; 659.9) 2280 (500.7; 4068) 3.4 (2.1; 6.8) 20 (0; 40) 0 (0; 0)
 Serology‑positive and PCR‑negative 6 (3) 193.9 (103.4; 685.3) 4456 (1756; 5734) 8.9 (1.4; 16.1) 80 (70;140) 0 (0; 0)
 Serology‑ and PCR‑positive 1 (1) 276.3 2083.9 > 346.3 40960 125
 Apparently healthy 21 (18) 116 (63.7; 238.9) 2097 (205.7; 3976) 3.2 (1.4; 6.1) 20 (0; 40) 0 (0; 0)
 Sick 11 (18) 567.1 (276.3; 1747) 3509 (2326; 4967) 6.9 (4.1; 12.7) 20 (0; 80) 0 (0; 0)
 Total 32 (18) 203.5 (65.9; 586.7) 2360 (979.1; 4297) 3.7 (2.1; 8.1) 20 (0; 40) 0 (0; 0)
IFN‑γ non‑producer cats
 Serology‑ and PCR‑negative 115 (64) 0 (0; 0) 646.1 (137.9; 2279) 4.2 (2.4; 6.3) 20 (0; 40) 0 (0; 0)
 Serology‑positive and PCR‑negative 24 (13) 0 (0; 0) 803.2 (176; 2553) 7.65 (4.7; 14.2) 80 (50; 160) 0 (0; 0)
 Serology‑ and PCR‑positive 8 (4) 0 (0; 0) 1334 (303.8; 2370) 25.5 (9.7; 263.5) 320 (80; 1120) 60 (7.5; 170)
 Apparently healthy 98 (82) 0 (0; 0) 587.5 (127.4; 2449) 4.3 (2.6; 6.7) 40 (0; 40) 0 (0; 0)
 Sick 49 (82) 0 (0; 0) 1019 (204.7; 2219) 5.8 (3.0; 8.9) 20 (10; 40) 0 (0; 0)
Total 147 (82) 0 (0; 0) 742.5 (150.7; 2407) 4.5 (2.8; 7.2) 40 (0; 40) 0 (0; 0)
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interpret due to the limitations of a clinical evaluation 
only based on physical examination and clinical history. 
In dogs with CanL, ConA-IFN-γ concentrations do not 
vary significantly in different LeishVet clinical stages, 
unless in the severe stage of disease (LeishVet stage IV) 
when a significantly lower concentration is observed [10].
The prevalence of anti-L. infantum antibodies obtained 
in this study by combination of both IFAT and ELISA 
results was similar in the two regions with an approxi-
mate value of 20%. It is not easy, therefore, to explain the 
higher frequency and level of positivity of ELISA in Sicil-
ian cats but these cats were more frequently found sick 
compared to Catalan cats (Table 2). Previous studies con-
ducted in Sicily were based on IFAT and, when the same 
cut-off was used, anti-L. infantum antibody prevalence 
ranged between 6.6–29% [19, 29–32]. Conversely, only 
two studies evaluated anti-L. infantum antibody preva-
lence in Catalonia; they both used ELISA and antibody 
prevalence was 1.7 and 5.3%, respectively [14, 33]. How-
ever, as already reported, we found a positive correlation 
between ELISA and IFAT [21].
The parasite load of cats was measured by blood PCR, 
thus some positive cats were possibly missed because 
blood is not the most sensitive tissue for the detection of 
L. infantum DNA in dogs and likewise with cats [7, 34]. 
However, all PCR-positive cats were also antibody-posi-
tive and the level of L. infantum DNA in blood was posi-
tively correlated with the antibody level of cats. This is 
not a common finding in cats from L. infantum endemic 
areas but, compared to other studies, we used two sero-
logical techniques and therefore the sensitivity of serol-
ogy was increased [19, 20, 35].
In this study, most IFNγ-p cats were negative to L. 
infantum antibody and DNA detection in blood (25/32, 
78%). This finding means that the combination of sero-
logical and molecular tests with L. infantum-specific 
IFN-γ evaluation offered a more accurate overall esti-
mation of the exposure to L. infantum of cats under 
study. In fact, the prevalence of L. infantum was 5% 
for blood PCR and 22% for antibody detection but the 
combination of results obtained by serological and 
molecular testing did not increase the percentage of 
positivity because all PCR positive cats were also posi-
tive for L. infantum antibodies (Fig. 1). However, when 
also considering positivity for L. infantum-specific 
IFN-γ production, the overall L. infantum prevalence 
raised to 36%. These data confirm that a consider-
able percentage of the studied cats had contact with L. 
infantum and that detection of cell-mediated immune 
response by measuring specific IFN-γ production pro-
vides a better estimation of exposure of cats to L. infan-
tum in endemic areas as seen in dogs with different 
techniques [34, 36].
Conclusions
As expected, cats from endemic areas produce IFN-γ 
after ex vivo blood stimulation with LSA and therefore 
are able to activate a cell-mediated adaptive immune 
response against the parasite that is variably associated 
with antibody or blood PCR positivity. The association 
of this assay to serological and molecular tests provides a 
better estimate of cat exposure to L. infantum.
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